52P Assessment of futibatinib exposure–response (E–R) relationships in patients with advanced solid tumors, including cholangiocarcinoma (CCA)

Authors :: Toshihiko Doi
H-T. Arkenau
Funda Meric-Bernstam
Ikuo Yamamiya
Volker Wacheck
K. Li
F. Yamashita
Antoine Hollebecque
John Bridgewater
Lipika Goyal
Source :: Annals of Oncology. 32:S378-S379
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Medicine
In patient
Hematology
business
Exposure response

Tools